Search - tctmd.com

Displaying 21 - 40 of 317

Sort: Relevancy | Date

News Daily News

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

Caitlin E. Cox

July 10, 2020

News Daily News

ILLUMENATE EU: No Higher Paclitaxel-Related Deaths as Talk Turns to Patency

L.A. McKeown

July 02, 2020

News Daily News

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Caitlin E. Cox

June 18, 2020

News Daily News

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

Caitlin E. Cox

May 08, 2020

News Daily News

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

L.A. McKeown

March 09, 2020

News Daily News

Balloon-Free PCI for SVG Stenosis Offers Ongoing Advantages: DIVA

Caitlin E. Cox

February 11, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Daily News

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

L.A. McKeown

January 15, 2020

News Daily News

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

Caitlin E. Cox

July 11, 2019

News Daily News

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

L.A. McKeown

June 20, 2019

News Daily News

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Yael L. Maxwell

May 15, 2019

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

L.A. McKeown

March 01, 2019

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Todd Neale

January 15, 2019

News Daily News

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

Yael L. Maxwell

November 05, 2018

News Daily News

FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease

Caitlin E. Cox

October 05, 2018

News Daily News

Ultrathin-Strut DES Outperform Second-Gen DES at 1 Year: Meta-analysis

Caitlin E. Cox

June 28, 2018

News Daily News

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

L.A. McKeown

May 08, 2018

News Daily News

Uncomplicated TLR After PCI Linked With Worse Mortality

Michael O'Riordan

April 20, 2018

News Daily News

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

Yael L. Maxwell

February 26, 2018

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

Advertisement

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

ILLUMENATE EU: No Higher Paclitaxel-Related Deaths as Talk Turns to Patency

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

Balloon-Free PCI for SVG Stenosis Offers Ongoing Advantages: DIVA

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease

Ultrathin-Strut DES Outperform Second-Gen DES at 1 Year: Meta-analysis

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

Uncomplicated TLR After PCI Linked With Worse Mortality

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content